538 related articles for article (PubMed ID: 26109801)
21. [Mechanism of Astragaloside prevents cholestatic liver fibrosis through inhibition of Notch signaling activation].
Mu YP; Zhang X; Fan WW; Li XW; Chen GF; Chen JM; Zhang H; Liu P
Zhonghua Gan Zang Bing Za Zhi; 2017 Aug; 25(8):575-582. PubMed ID: 29056006
[No Abstract] [Full Text] [Related]
22. D-chiro-inositol effectively attenuates cholestasis in bile duct ligated rats by improving bile acid secretion and attenuating oxidative stress.
Zhao SS; Li NR; Zhao WL; Liu H; Ge MX; Zhang YX; Zhao LY; You XF; He HW; Shao RG
Acta Pharmacol Sin; 2018 Feb; 39(2):213-221. PubMed ID: 28748913
[TBL] [Abstract][Full Text] [Related]
23. [Inhibitory effect of angiotensin blockade on hepatic fibrosis in common bile duct-ligated rats].
Park DH; Baik SK; Choi YH; Kim MY; Rhim DW; Kim JW; Kwon SO; Cho MY; Kim CH; Ahn SC
Korean J Hepatol; 2007 Mar; 13(1):61-9. PubMed ID: 17380076
[TBL] [Abstract][Full Text] [Related]
24. Silymarin-loaded Eudragit(®) RS100 nanoparticles improved the ability of silymarin to resolve hepatic fibrosis in bile duct ligated rats.
Younis N; Shaheen MA; Abdallah MH
Biomed Pharmacother; 2016 Jul; 81():93-103. PubMed ID: 27261582
[TBL] [Abstract][Full Text] [Related]
25. The anti-fibrotic effect of liver growth factor is associated with decreased intrahepatic levels of matrix metalloproteinases 2 and 9 and transforming growth factor beta 1 in bile duct-ligated rats.
Díaz-Gil JJ; García-Monzón C; Rúa C; Martín-Sanz P; Cereceda RM; Miquilena-Colina ME; Machín C; Fernández-Martínez A; García-Cañero R
Histol Histopathol; 2008 May; 23(5):583-91. PubMed ID: 18283643
[TBL] [Abstract][Full Text] [Related]
26. HIF-1 α as a Key Factor in Bile Duct Ligation-Induced Liver Fibrosis in Rats.
Moczydlowska J; Miltyk W; Hermanowicz A; Lebensztejn DM; Palka JA; Debek W
J Invest Surg; 2017 Feb; 30(1):41-46. PubMed ID: 27260943
[TBL] [Abstract][Full Text] [Related]
27. Tetrathiomolybdate protects against bile duct ligation-induced cholestatic liver injury and fibrosis.
Song M; Song Z; Barve S; Zhang J; Chen T; Liu M; Arteel GE; Brewer GJ; McClain CJ
J Pharmacol Exp Ther; 2008 May; 325(2):409-16. PubMed ID: 18299419
[TBL] [Abstract][Full Text] [Related]
28. Chromium attenuates hepatic damage in a rat model of chronic cholestasis.
Chen WY; Chen CJ; Liao JW; Mao FC
Life Sci; 2009 Apr; 84(17-18):606-14. PubMed ID: 19302800
[TBL] [Abstract][Full Text] [Related]
29. Melatonin attenuates oxidative stress, liver damage and hepatocyte apoptosis after bile-duct ligation in rats.
Aktas C; Kanter M; Erboga M; Mete R; Oran M
Toxicol Ind Health; 2014 Oct; 30(9):835-44. PubMed ID: 23095487
[TBL] [Abstract][Full Text] [Related]
30. Effects of Yinchenhao decoction on self-regulation of renin-angiotensin system by targeting angiotensin converting enzyme 2 in bile duct-ligated rat liver.
Wu L; Zhou PQ; Xie JW; Zhu R; Zhou SC; Wang G; Wu ZX; Hao S
J Huazhong Univ Sci Technolog Med Sci; 2015 Aug; 35(4):519-524. PubMed ID: 26223920
[TBL] [Abstract][Full Text] [Related]
31. Vitamin K1 attenuates bile duct ligation-induced liver fibrosis in rats.
Jiao K; Sun Q; Chen B; Li S; Lu J
Scand J Gastroenterol; 2014 Jun; 49(6):715-21. PubMed ID: 24742111
[TBL] [Abstract][Full Text] [Related]
32. Glechoma hederacea extracts attenuate cholestatic liver injury in a bile duct-ligated rat model.
Wang YY; Lin SY; Chen WY; Liao SL; Wu CC; Pan PH; Chou ST; Chen CJ
J Ethnopharmacol; 2017 May; 204():58-66. PubMed ID: 28416441
[TBL] [Abstract][Full Text] [Related]
33. Bile duct ligation-induced biliary hyperplasia, hepatic injury, and fibrosis are reduced in mast cell-deficient Kit
Hargrove L; Kennedy L; Demieville J; Jones H; Meng F; DeMorrow S; Karstens W; Madeka T; Greene J; Francis H
Hepatology; 2017 Jun; 65(6):1991-2004. PubMed ID: 28120369
[TBL] [Abstract][Full Text] [Related]
34. Hepatoprotective and antifibrotic effects of sodium molybdate in a rat model of bile duct ligation.
Ale-Ebrahim M; Eidi A; Mortazavi P; Tavangar SM; Tehrani DM
J Trace Elem Med Biol; 2015 Jan; 29():242-8. PubMed ID: 25084733
[TBL] [Abstract][Full Text] [Related]
35. Conditional loss of heparin-binding EGF-like growth factor results in enhanced liver fibrosis after bile duct ligation in mice.
Takemura T; Yoshida Y; Kiso S; Kizu T; Furuta K; Ezaki H; Hamano M; Egawa M; Chatani N; Kamada Y; Imai Y; Higashiyama S; Iwamoto R; Mekada E; Takehara T
Biochem Biophys Res Commun; 2013 Jul; 437(2):185-91. PubMed ID: 23743191
[TBL] [Abstract][Full Text] [Related]
36. Beneficial effect of docosahexaenoic acid on cholestatic liver injury in rats.
Chen WY; Lin SY; Pan HC; Liao SL; Chuang YH; Yen YJ; Lin SY; Chen CJ
J Nutr Biochem; 2012 Mar; 23(3):252-64. PubMed ID: 21497498
[TBL] [Abstract][Full Text] [Related]
37. Characterization of time-related changes after experimental bile duct ligation.
Georgiev P; Jochum W; Heinrich S; Jang JH; Nocito A; Dahm F; Clavien PA
Br J Surg; 2008 May; 95(5):646-56. PubMed ID: 18196571
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of integrin alphavbeta6 on cholangiocytes blocks transforming growth factor-beta activation and retards biliary fibrosis progression.
Patsenker E; Popov Y; Stickel F; Jonczyk A; Goodman SL; Schuppan D
Gastroenterology; 2008 Aug; 135(2):660-70. PubMed ID: 18538673
[TBL] [Abstract][Full Text] [Related]
39. Increased Expression of S100B and RAGE in a Mouse Model of Bile Duct Ligation-induced Liver Fibrosis.
Park JW; Kim MJ; Kim SE; Kim HJ; Jeon YC; Shin HY; Park SJ; Jang MK; Kim DJ; Park CK; Choi EK
J Korean Med Sci; 2021 Apr; 36(14):e90. PubMed ID: 33847081
[TBL] [Abstract][Full Text] [Related]
40. Effects of bicyclol on dimethylnitrosamine-induced liver fibrosis in mice and its mechanism of action.
Hu QW; Liu GT
Life Sci; 2006 Jul; 79(6):606-12. PubMed ID: 16603200
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
